Carmichael Hill & Associates’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Carmichael Hill & Associates’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Hold	0	–	–	–	507
2024 Q2	–	Hold	0	–	–	–	497
2024 Q1	–	Hold	0	–	–	–	486
2023 Q4	–	Hold	0	–	–	–	364
2023 Q3	–	Hold	0	–	–	–	382
2023 Q2	–	Hold	0	–	–	–	364
2023 Q1	–	Hold	0	–	–	–	396
2022 Q4	–	Hold	0	–	–	–	260
2022 Q3	–	Hold	0	–	–	–	274
2022 Q2	–	Sell	-900	Closed	-$67.6K	–	288
2022 Q1	$81K	Buy	900 +200	+29%	+$18.5K	0.04%	276
2021 Q4	$78K	Hold	700	–	–	0.04%	285
2021 Q3	$88K	Buy	700 +500	+250%	+$64.4K	0.04%	264
2021 Q2	$27K	Hold	200	–	–	0.01%	479
2021 Q1	$27K	Buy	+200	New	+$29.9K	0.01%	456

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Carmichael Hill & Associates's XBI Position: Q3 2024 in Review

Carmichael Hill & Associates held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q3 2024 at 82 shares worth $8.1K. The position accounts for ﹤0.01% of the portfolio, ranked #613.

Carmichael Hill & Associates first reported a position in XBI in Q4 2019 and has held it in 20 quarters since. The position peaked at $56K in Q1 2022. 769 funds tracked by Wall St. Rank hold XBI as of Q3 2024.

Carmichael Hill & Associates held 82 shares of State Street SPDR S&P Biotech ETF worth $8.1K as of Q3 2024.
Carmichael Hill & Associates left its State Street SPDR S&P Biotech ETF share count unchanged in Q3 2024.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Carmichael Hill & Associates's portfolio in Q3 2024, its #613 holding.
Carmichael Hill & Associates first reported a position in State Street SPDR S&P Biotech ETF in Q4 2019 and has held it in 20 quarters since.
Carmichael Hill & Associates's State Street SPDR S&P Biotech ETF position peaked at $56K in Q1 2022.
769 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.